Trending Topic

3D illustration of human brain on black background
23 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Joseph Samaha, Jim Dagher, Shayan Abdollah Zadegan

Huntington’s disease (HD) is a neurodegenerative disease inherited in an autosomal dominant manner. It is caused by an expansion of cytosine, adenine, guanine (CAG) repeats within the huntingtin (HTT) gene, which is located on chromosome 4. This pathological expansion of CAG repeats results in the production of a mutant huntingtin protein with an abnormally long polyglutamine […]

Said Beydoun, AAN 2019 – Current and emerging therapies for myasthenia gravis (Part 1)

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 29th 2019

US Neurology Editor-in-Chief, Said Beydoun (Keck Medical Center of USC, University of Southern California, CA, USA), discusses challenges in the diagnosis of myasthenia gravis and limitations of existing therapies.

Questions

  1. What are the major challenges in the diagnosis of myasthenia gravis? (0:04)
  2. What are the limitations of glucocorticoids and other immunosuppressive therapies in the treatment of myasthenia gravis? (1:58)

View Part 2 of this expert interview here.

Speaker disclosures: Said Beydoun has received research grants from Argenx, Catalyst and UCB, and is a consultant, advisory board member and speaker for Alexion.

Filmed at the American Academy of Neurology (AAN) Annual Meeting, Philadelphia, USA, May 2019.

 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup